Gene: TMEM81
Official Full Name: transmembrane protein 81provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13280 | TMEM81 Knockout cell line (HeLa) | Human | TMEM81 | 1:3~1:6 | Negative | Online Inquiry |
KO13281 | TMEM81 Knockout cell line (HCT 116) | Human | TMEM81 | 1:2~1:4 | Negative | Online Inquiry |
KO13282 | TMEM81 Knockout cell line (HEK293) | Human | TMEM81 | 1:3~1:6 | Negative | Online Inquiry |
KO13283 | TMEM81 Knockout cell line (A549) | Human | TMEM81 | 1:3~1:4 | Negative | Online Inquiry |
TMEM81 Gene Knockout Cell Lines are genetically engineered cell lines designed for the comprehensive study of the TMEM81 gene, which is implicated in various cellular processes, including cell signaling and membrane dynamics. These knockout cell lines are created by using CRISPR-Cas9 technology to effectively disable the TMEM81 gene, providing researchers with invaluable tools to explore the functions and roles of this gene in cellular physiology and pathology.
The primary mechanism of action involves the precise deletion or alteration of the TMEM81 gene within the cellular genome, leading to a complete loss of TMEM81 protein expression. This deficiency allows researchers to dissect the cellular pathways and mechanisms impacted by TMEM81 absence, offering insights into its potential involvement in disease states and development processes. Understanding these mechanisms is crucial, particularly in the context of diseases where membrane integrity and cell signaling are disrupted.
From a scientific standpoint, TMEM81 Gene Knockout Cell Lines serve as essential platforms for research in both academia and clinical settings. Their applications range from basic cellular biology studies to more complex disease modeling, including cancer research and neurological disorders. By utilizing these models, scientists can identify potential therapeutic targets and validate novel treatment strategies, ultimately contributing to advancements in translational medicine.
What truly sets TMEM81 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability. The CRISPR technology used ensures that unwanted off-target effects are minimized, resulting in more accurate studies. Additionally, these cell lines are thoroughly characterized, allowing for reproducibility and confidence in experimental results.
The value of TMEM81 Gene Knockout Cell Lines lies in their ability to drive significant discoveries and foster innovative approaches in research and therapeutics, making them indispensable to any laboratory focused on gene function and disease mechanisms. Our company, with its extensive expertise in gene editing and cell line development, stands at the forefront of providing high-quality biological products that empower researchers and clinicians alike in their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.